Articles About NYSE:LLY
December 06, 2013
After failing to meet the company's primary goals for the drug during three late-stage trials, Eli Lilly will cease the development of edivoxetine.
November 11, 2013
Analysis of Top healthcare Business News: 4 Healthcare Stock Stories to Start Off the Week's Investment Wellness